NCT03008850 - Shivering Prevention During Cesarean Section by Intrathecal Injection of Magnesium Sulfate | Biotech Hunter

Enrollment

84

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Cesarean Section; Shivering

Interventions

DRUG

MgSo4

"Patients will be randomly allocated to one of two groups:~Group (M): 2 ml (10 mg) of 0.5% heavy bupivacaine plus 0.5 ml (25 mg) MgSO4 will be injected intrathecally.~Group(P): 2 ml (10 mg) of 0.5% heavy bupivacaine plus 0.5 ml normal saline will be injected intrathecally."

DRUG

Placebo

"Patients will be randomly allocated to one of two groups:~Group (M): 2 ml (10 mg) of 0.5% heavy bupivacaine plus 0.5 ml (25 mg) MgSO4 will be injected intrathecally.~Group(P): 2 ml (10 mg) of 0.5% heavy bupivacaine plus 0.5 ml normal saline will be injected intrathecally."

Trial Locations (1)

71515

Assiut university hospital, Asyut